
Sign up to save your podcasts
Or


Guest: Aaron M. Potretzke, M.D. (@potretzke)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.
Specific topics:
Additional resources:
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
By Mayo Clinic4.4
268268 ratings
Guest: Aaron M. Potretzke, M.D. (@potretzke)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.
Specific topics:
Additional resources:
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

136 Listeners

319 Listeners

698 Listeners

496 Listeners

250 Listeners

259 Listeners

3,344 Listeners

1,159 Listeners

195 Listeners

90 Listeners

513 Listeners

364 Listeners

12 Listeners

252 Listeners

18 Listeners

15 Listeners

9 Listeners

430 Listeners

369 Listeners

45 Listeners

14 Listeners